{"GOLD_15": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 6}, {"id": "whoBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatActionBox", "group": "card", "size": 4}, {"id": "new_to_old", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 30}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "new_to_old", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}]}}, "GOLD_31": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 4}, {"id": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "group": "document", "size": 30}, {"id": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "group": "document", "size": 30}], "links": [{"source": "pfizer", "target": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "value": 1}, {"source": "pfizer", "target": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 8}, {"id": "whyPositiveBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 2}, {"id": "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says", "group": "document", "size": 30}, {"id": "whereBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 4}, {"id": "whoBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 21}], "links": [{"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "thromboembolic-events-don-t-appear-higher-in-vaccinated-population-ema-says", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}]}}, "GOLD_14": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 24}, {"id": "whoBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatTopicBox", "group": "card", "size": 8}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 2}, {"id": "whereBox", "group": "card", "size": 8}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 10}, {"id": "whyPositiveBox", "group": "card", "size": 2}, {"id": "new_to_old", "group": "timeline", "size": 2}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "consistent", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "new_to_old", "value": 1}]}}, "GOLD_17": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 4}, {"id": "whoBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatActionBox", "group": "card", "size": 2}, {"id": "old_to_new", "group": "timeline", "size": 1}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}]}}, "GOLD_12": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 4}, {"id": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "group": "document", "size": 30}, {"id": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "group": "document", "size": 30}], "links": [{"source": "pfizer", "target": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "value": 1}, {"source": "pfizer", "target": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 30}, {"id": "whoBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whereBox", "group": "card", "size": 8}, {"id": "consistent", "group": "timeline", "size": 20}, {"id": "old_to_new", "group": "timeline", "size": 2}, {"id": "whatTopicBox", "group": "card", "size": 10}, {"id": "old_to_new", "group": "timeline", "size": 8}, {"id": "consistent", "group": "timeline", "size": 2}, {"id": "new_to_old", "group": "timeline", "size": 2}, {"id": "whatActionBox", "group": "card", "size": 2}, {"id": "new_to_old", "group": "timeline", "size": 4}, {"id": "whyPositiveBox", "group": "card", "size": 4}, {"id": "old_to_new", "group": "timeline", "size": 2}, {"id": "consistent", "group": "timeline", "size": 1}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}, {"source": "whatTopicBox", "target": "consistent", "value": 1}, {"source": "whatTopicBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "old_to_new", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}]}}, "GOLD_18": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 10}, {"id": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "group": "document", "size": 30}, {"id": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "group": "document", "size": 30}, {"id": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "group": "document", "size": 30}, {"id": "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty", "group": "document", "size": 30}, {"id": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "group": "document", "size": 30}], "links": [{"source": "pfizer", "target": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "value": 1}, {"source": "pfizer", "target": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "value": 1}, {"source": "pfizer", "target": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "value": 1}, {"source": "pfizer", "target": "ec-signs-up-for-1-8-billion-additional-doses-of-comirnaty", "value": 1}, {"source": "pfizer", "target": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 2}, {"id": "whatTopicBox", "group": "card", "size": 2}, {"id": "old_to_new", "group": "timeline", "size": 1}], "links": [{"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}]}}, "GOLD_11": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 32}, {"id": "whoBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whereBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatTopicBox", "group": "card", "size": 10}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 19}, {"id": "new_to_old", "group": "timeline", "size": 2}, {"id": "whyPositiveBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 22}, {"id": "whatActionBox", "group": "card", "size": 8}, {"id": "old_to_new", "group": "timeline", "size": 15}, {"id": "consistent", "group": "timeline", "size": 15}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "consistent", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}, {"source": "whatTopicBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}, {"source": "whatActionBox", "target": "consistent", "value": 1}]}}, "GOLD_9": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 18}, {"id": "whereBox", "group": "card", "size": 10}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 30}, {"id": "new_to_old", "group": "timeline", "size": 6}, {"id": "whoBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatTopicBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 30}], "links": [{"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "whereBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "consistent", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}]}}, "GOLD_2": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 12}, {"id": "coronavirus-vaccine-approved-for-use-in-children", "group": "document", "size": 30}, {"id": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "group": "document", "size": 30}, {"id": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "group": "document", "size": 16}, {"id": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "group": "document", "size": 11}, {"id": "march-april-2021-pharmaceutical-m-a-round-up", "group": "document", "size": 5}, {"id": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "group": "document", "size": 2}], "links": [{"source": "pfizer", "target": "coronavirus-vaccine-approved-for-use-in-children", "value": 1}, {"source": "pfizer", "target": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "value": 1}, {"source": "pfizer", "target": "vaccine-companies-shareholders-profits-would-pay-to-vaccinate-africa-say-campaigners", "value": 1}, {"source": "pfizer", "target": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "value": 1}, {"source": "pfizer", "target": "march-april-2021-pharmaceutical-m-a-round-up", "value": 1}, {"source": "pfizer", "target": "sosei-heptares-hits-milestone-in-pfizer-collaboration", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 20}, {"id": "whoBox", "group": "card", "size": 8}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "group": "document", "size": 7}, {"id": "whatTopicBox", "group": "card", "size": 2}, {"id": "new_to_old", "group": "timeline", "size": 21}, {"id": "whereBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 7}, {"id": "new_to_old", "group": "timeline", "size": 1}, {"id": "whyPositiveBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 7}, {"id": "old_to_new", "group": "timeline", "size": 3}, {"id": "whyNegativeBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 4}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}, {"source": "whyPositiveBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whyNegativeBox", "value": 1}, {"source": "whyNegativeBox", "target": "consistent", "value": 1}]}}, "GOLD_19": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 2}, {"id": "whoBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 30}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}]}}, "GOLD_4": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 8}, {"id": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "group": "document", "size": 30}, {"id": "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine", "group": "document", "size": 4}, {"id": "trial-in-children-could-help-increase-vaccine-coverage", "group": "document", "size": 3}, {"id": "vaccines-seem-effective-against-brazilian-variant", "group": "document", "size": 3}], "links": [{"source": "pfizer", "target": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "value": 1}, {"source": "pfizer", "target": "record-breaking-sales-of-24-8bn-by-2021-predicted-for-pfizer-biontech-s-vaccine", "value": 1}, {"source": "pfizer", "target": "trial-in-children-could-help-increase-vaccine-coverage", "value": 1}, {"source": "pfizer", "target": "vaccines-seem-effective-against-brazilian-variant", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 10}, {"id": "whoBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatActionBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 29}, {"id": "old_to_new", "group": "timeline", "size": 6}, {"id": "whereBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 14}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "consistent", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}]}}, "GOLD_3": {"text": {}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 56}, {"id": "whyNegativeBox", "group": "card", "size": 16}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "group": "document", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 12}, {"id": "new_to_old", "group": "timeline", "size": 5}, {"id": "whereBox", "group": "card", "size": 12}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "old_to_new", "group": "timeline", "size": 14}, {"id": "whatActionBox", "group": "card", "size": 10}, {"id": "old_to_new", "group": "timeline", "size": 30}, {"id": "new_to_old", "group": "timeline", "size": 3}, {"id": "consistent", "group": "timeline", "size": 1}, {"id": "whoBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whatTopicBox", "group": "card", "size": 4}, {"id": "old_to_new", "group": "timeline", "size": 15}, {"id": "new_to_old", "group": "timeline", "size": 4}, {"id": "whyPositiveBox", "group": "card", "size": 8}, {"id": "consistent", "group": "timeline", "size": 18}, {"id": "old_to_new", "group": "timeline", "size": 1}], "links": [{"source": "astrazeneca", "target": "whyNegativeBox", "value": 1}, {"source": "whyNegativeBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "value": 1}, {"source": "whyNegativeBox", "target": "old_to_new", "value": 1}, {"source": "whyNegativeBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}, {"source": "whatActionBox", "target": "new_to_old", "value": 1}, {"source": "whatActionBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}, {"source": "whatTopicBox", "target": "new_to_old", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}, {"source": "whyPositiveBox", "target": "old_to_new", "value": 1}]}}, "GOLD_24": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 6}, {"id": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "group": "document", "size": 30}, {"id": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "group": "document", "size": 30}, {"id": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "group": "document", "size": 30}], "links": [{"source": "pfizer", "target": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "value": 1}, {"source": "pfizer", "target": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "value": 1}, {"source": "pfizer", "target": "us-cdc-recommends-use-of-pfizer-biontech-jab-in-adolescents", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 62}, {"id": "whereBox", "group": "card", "size": 12}, {"id": "old_to_new", "group": "timeline", "size": 30}, {"id": "consistent", "group": "timeline", "size": 22}, {"id": "whoBox", "group": "card", "size": 6}, {"id": "consistent", "group": "timeline", "size": 30}, {"id": "whyPositiveBox", "group": "card", "size": 16}, {"id": "old_to_new", "group": "timeline", "size": 21}, {"id": "new_to_old", "group": "timeline", "size": 9}, {"id": "consistent", "group": "timeline", "size": 17}, {"id": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "group": "document", "size": 1}, {"id": "whatActionBox", "group": "card", "size": 12}, {"id": "consistent", "group": "timeline", "size": 25}, {"id": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "group": "document", "size": 5}, {"id": "full-program-for-astrazeneca-at-asco-2021", "group": "document", "size": 4}, {"id": "old_to_new", "group": "timeline", "size": 6}, {"id": "whatTopicBox", "group": "card", "size": 12}, {"id": "consistent", "group": "timeline", "size": 25}, {"id": "full-program-for-astrazeneca-at-asco-2021", "group": "document", "size": 8}, {"id": "new_to_old", "group": "timeline", "size": 2}, {"id": "old_to_new", "group": "timeline", "size": 2}, {"id": "whyNegativeBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 14}, {"id": "old_to_new", "group": "timeline", "size": 2}], "links": [{"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whyPositiveBox", "value": 1}, {"source": "whyPositiveBox", "target": "old_to_new", "value": 1}, {"source": "whyPositiveBox", "target": "new_to_old", "value": 1}, {"source": "whyPositiveBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "ema-finds-possible-link-of-astrazeneca-s-covid-19-vaccine-with-rare-blood-clots", "value": 1}, {"source": "astrazeneca", "target": "whatActionBox", "value": 1}, {"source": "whatActionBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "eu-sues-vaccine-developer-while-usa-donates-excess-supplies", "value": 1}, {"source": "consistent", "target": "full-program-for-astrazeneca-at-asco-2021", "value": 1}, {"source": "whatActionBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "consistent", "value": 1}, {"source": "consistent", "target": "full-program-for-astrazeneca-at-asco-2021", "value": 1}, {"source": "whatTopicBox", "target": "new_to_old", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whyNegativeBox", "value": 1}, {"source": "whyNegativeBox", "target": "consistent", "value": 1}, {"source": "whyNegativeBox", "target": "old_to_new", "value": 1}]}}, "GOLD_28": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 12}, {"id": "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine", "group": "document", "size": 30}, {"id": "coronavirus-vaccine-approved-for-use-in-children", "group": "document", "size": 30}, {"id": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "group": "document", "size": 23}, {"id": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "group": "document", "size": 21}, {"id": "latest-pfizer-biontech-results-offer-youthful-optimism", "group": "document", "size": 19}, {"id": "trial-in-children-could-help-increase-vaccine-coverage", "group": "document", "size": 17}], "links": [{"source": "pfizer", "target": "pfizer-and-biontech-initiate-fda-rolling-bla-submission-for-their-covid-19-vaccine", "value": 1}, {"source": "pfizer", "target": "coronavirus-vaccine-approved-for-use-in-children", "value": 1}, {"source": "pfizer", "target": "pfizer-adds-3-5-billion-in-first-quarter-vaccine-sales", "value": 1}, {"source": "pfizer", "target": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "value": 1}, {"source": "pfizer", "target": "latest-pfizer-biontech-results-offer-youthful-optimism", "value": 1}, {"source": "pfizer", "target": "trial-in-children-could-help-increase-vaccine-coverage", "value": 1}]}, "viz": {}}, "GOLD_16": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 10}, {"id": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "group": "document", "size": 30}, {"id": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "group": "document", "size": 29}, {"id": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "group": "document", "size": 20}, {"id": "vaccines-seem-effective-against-brazilian-variant", "group": "document", "size": 19}, {"id": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "group": "document", "size": 11}], "links": [{"source": "pfizer", "target": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "value": 1}, {"source": "pfizer", "target": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "value": 1}, {"source": "pfizer", "target": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "value": 1}, {"source": "pfizer", "target": "vaccines-seem-effective-against-brazilian-variant", "value": 1}, {"source": "pfizer", "target": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "value": 1}]}, "viz": {}}, "GOLD_20": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 4}, {"id": "latest-pfizer-biontech-results-offer-youthful-optimism", "group": "document", "size": 17}, {"id": "pfizer-expands-anti-infectives-pipeline-with-acquisition", "group": "document", "size": 4}], "links": [{"source": "pfizer", "target": "latest-pfizer-biontech-results-offer-youthful-optimism", "value": 1}, {"source": "pfizer", "target": "pfizer-expands-anti-infectives-pipeline-with-acquisition", "value": 1}]}, "viz": {"nodes": [{"id": "astrazeneca", "group": "task", "size": 8}, {"id": "whoBox", "group": "card", "size": 2}, {"id": "consistent", "group": "timeline", "size": 17}, {"id": "whereBox", "group": "card", "size": 4}, {"id": "consistent", "group": "timeline", "size": 12}, {"id": "old_to_new", "group": "timeline", "size": 4}, {"id": "whatTopicBox", "group": "card", "size": 2}, {"id": "old_to_new", "group": "timeline", "size": 1}], "links": [{"source": "astrazeneca", "target": "whoBox", "value": 1}, {"source": "whoBox", "target": "consistent", "value": 1}, {"source": "astrazeneca", "target": "whereBox", "value": 1}, {"source": "whereBox", "target": "consistent", "value": 1}, {"source": "whereBox", "target": "old_to_new", "value": 1}, {"source": "astrazeneca", "target": "whatTopicBox", "value": 1}, {"source": "whatTopicBox", "target": "old_to_new", "value": 1}]}}, "GOLD_30": {"text": {"nodes": [{"id": "pfizer", "group": "task", "size": 8}, {"id": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "group": "document", "size": 16}, {"id": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "group": "document", "size": 13}, {"id": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "group": "document", "size": 12}, {"id": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "group": "document", "size": 7}], "links": [{"source": "pfizer", "target": "myfembree-approved-for-heavy-menstrual-bleeding-associated-with-uterine-fibroids", "value": 1}, {"source": "pfizer", "target": "uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "value": 1}, {"source": "pfizer", "target": "pfizer-biontech-covid-19-vaccine-shelf-life-extended-to-31-days", "value": 1}, {"source": "pfizer", "target": "pfizer-takes-aim-at-coronavirus-and-vaccines-market", "value": 1}]}, "viz": {}}}